c-car066
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 18, 2019 (NCT04316624)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- B-lymphocyte antigen CD20Immunity, passive
MS4A1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05784441 | Phase 1 | Nov 6, 2023 | — |
| NCT04316624 | Phase 1 | Sep 18, 2019 | Chinese Academy of Medical Sciences, Shanghai Celluar Biopharmaceutical Group Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Shanghai Celluar Biopharmaceutical Group Ltd. | Academic/Hospital | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1